Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bluebird Bio (NQ: BLUE ) 0.6887 +0.0117 (+1.73%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Bluebird Bio < Previous 1 2 ... 6 7 8 9 10 11 12 13 Next > Do You Have Biotech FOMO? Why Cogent, Arvinas And Others Are Flying July 06, 2022 Biotech stocks continued going gangbusters Wednesday. Here's why, experts say. Via Investor's Business Daily Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday July 06, 2022 Gainers Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday. Via Benzinga Bluebird (BLUE) Stock Soars 25% Following 2 FDA Recommendations June 13, 2022 Bluebird Bio (BLUE) stock is gaining on Monday following positive news last week from an advisory committee set up by the FDA. Via InvestorPlace FDA Advisory Committee Backs Bluebird Bio's Blood Disorder Gene Therapy June 13, 2022 Via Benzinga Tesla, Ra Medical Systems And 51 Stocks Moving In Tuesday's Mid-Day Session July 05, 2022 Gainers Ra Medical Systems, Inc. (NASDAQ: RMED) shares jumped 69.6% to $0.5240 after the company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session June 23, 2022 Via Benzinga 44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More June 23, 2022 Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering. Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session June 22, 2022 Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.3% to $1.03 during Wednesday's after-market session. The company's market cap stands at $33.2 million. Via Benzinga 7 Oversold Stocks on the Verge of Blasting Off June 22, 2022 Although terrible economic data has imposed a bloodbath in the market, certain oversold stocks are ripe for a potential comeback. Via InvestorPlace The 5 Top Profit & Protection Stocks to Buy for 2022 June 17, 2022 It's important to know which quantitative factors make a stock worthwhile. These five have the attributes needed for success. Via InvestorPlace Dow Jones Turns Lower; Revlon Shares Jump June 17, 2022 U.S. stocks pared gains midway through trading, with the Dow Jones dropping around 100 points on Friday. Via Benzinga Bluebird Bio Secures FDA Advisory Committee's Endorsement For Neurodegenerative Disease Drug June 09, 2022 The U.S. Via Benzinga FDA Sounds Positive On Bluebird's One Gene Therapy But Doubts Another June 07, 2022 Via Benzinga 89 Biggest Movers From Friday June 21, 2022 Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy. Via Benzinga 33 Stocks Moving In Friday's Mid-Day Session June 17, 2022 Gainers Revlon, Inc. (NYSE: REV) gained 81.5% to $3.54 following a report suggesting Reliance Industries is considering buying out the company, which recently filed for bankruptcy. Via Benzinga U.S. Markets Open Higher; Dow Rises Around 200 Points June 17, 2022 U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Friday. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session June 14, 2022 Via Benzinga 82 Biggest Movers From Yesterday June 15, 2022 Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 126.5% to settle at $2.65 on Tuesday. Via Benzinga Mid-Afternoon Market Update: Gold Down Over 2%; Electric Last Mile Solutions Shares Plummet June 13, 2022 U.S. stocks traded lower toward the end of trading, with the S&P 500 dropping by more than 3% on Monday. Via Benzinga 93 Biggest Movers From Yesterday June 14, 2022 Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on Monday after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session June 13, 2022 Via Benzinga Analysts Consider CRISPR Therapeutics' Blood Disorder Trial Data Encouraging, Impressive June 13, 2022 CRISPR Therapeutics (NASDAQ: CRSP) presented results from its ongoing Phase 1 COBALT-LYM CTX130 (exa-cel) trial, an allogeneic CAR-T cell therapy targeting CD70 for solid tumors and certain hematologic... Via Benzinga Mid-Day Market Update: Nasdaq Dips Over 400 Points; Day One Biopharmaceuticals Shares Jump June 13, 2022 U.S. stocks traded lower midway through trading, with the Nasdaq Composite tumbling by more than 400 points on Monday. Via Benzinga Mid-Morning Market Update: Markets Open Lower; Dow Drops 600 Points June 13, 2022 U.S. stocks traded lower this morning, with the Dow Jones dropping more than 600 points on Monday. Via Benzinga 70 Stocks Moving In Monday's Mid-Day Session June 13, 2022 Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric... Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session June 10, 2022 Gainers bluebird bio (NASDAQ:BLUE) shares rose 53.4% to $6.12 during Friday's after-market session. Trading volume for this security closed at 5.0 million, accounting for 206.3% of its average full-day... Via Benzinga 6 Biotech Stocks to Buy Now Ahead of These June Catalysts June 03, 2022 These biotech stocks face some key make-or-break events in June that could have big implication for their futures. Via InvestorPlace Stocks That Hit 52-Week Lows On Thursday June 02, 2022 During the Thursday's session, 100 stocks hit new 52-week lows. Via Benzinga TC BioPharm Reports Racing Toward What Could Be A Major Cancer Immunotherapy Breakthrough June 02, 2022 This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Via Benzinga Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates May 31, 2022 May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month,... Via Benzinga < Previous 1 2 ... 6 7 8 9 10 11 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.